Annual Current Liabilities
$17.64 M
+$9.86 M+126.64%
December 31, 2023
Summary
- As of February 8, 2025, AVTE annual total current liabilities is $17.64 million, with the most recent change of +$9.86 million (+126.64%) on December 31, 2023.
- During the last 3 years, AVTE annual current liabilities has risen by +$15.86 million (+894.19%).
- AVTE annual current liabilities is now at all-time high.
Performance
AVTE Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$10.31 M
-$6.71 M-39.39%
September 30, 2024
Summary
- As of February 8, 2025, AVTE quarterly total current liabilities is $10.31 million, with the most recent change of -$6.71 million (-39.39%) on September 30, 2024.
- Over the past year, AVTE quarterly current liabilities has dropped by -$7.32 million (-41.51%).
- AVTE quarterly current liabilities is now -41.51% below its all-time high of $17.64 million, reached on December 31, 2023.
Performance
AVTE Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
AVTE Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +126.6% | -41.5% |
| 3 y3 years | +894.2% | -41.5% |
| 5 y5 years | +2584.5% | -41.5% |
AVTE Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +591.6% | -41.5% | +304.5% |
| 5 y | 5-year | at high | +2584.5% | -41.5% | +481.4% |
| alltime | all time | at high | +2584.5% | -41.5% | +481.4% |
Aerovate Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $10.31 M(-39.4%) |
| Jun 2024 | - | $17.02 M(+9.7%) |
| Mar 2024 | - | $15.52 M(-12.0%) |
| Dec 2023 | $17.64 M(+126.6%) | $17.64 M(+19.8%) |
| Sep 2023 | - | $14.72 M(+10.8%) |
| Jun 2023 | - | $13.28 M(+24.9%) |
| Mar 2023 | - | $10.64 M(+36.7%) |
| Dec 2022 | $7.78 M | $7.78 M(+1.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $7.71 M(+105.1%) |
| Jun 2022 | - | $3.76 M(-20.1%) |
| Mar 2022 | - | $4.70 M(+84.4%) |
| Dec 2021 | $2.55 M(+43.7%) | $2.55 M(-33.3%) |
| Sep 2021 | - | $3.83 M(-8.8%) |
| Jun 2021 | - | $4.19 M(+135.3%) |
| Mar 2021 | - | $1.78 M(+0.5%) |
| Dec 2020 | $1.77 M(+170.0%) | $1.77 M |
| Dec 2019 | $657.00 K | - |
FAQ
- What is Aerovate Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Aerovate Therapeutics?
- What is Aerovate Therapeutics annual current liabilities year-on-year change?
- What is Aerovate Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Aerovate Therapeutics?
- What is Aerovate Therapeutics quarterly current liabilities year-on-year change?
What is Aerovate Therapeutics annual total current liabilities?
The current annual current liabilities of AVTE is $17.64 M
What is the all time high annual current liabilities for Aerovate Therapeutics?
Aerovate Therapeutics all-time high annual total current liabilities is $17.64 M
What is Aerovate Therapeutics annual current liabilities year-on-year change?
Over the past year, AVTE annual total current liabilities has changed by +$9.86 M (+126.64%)
What is Aerovate Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of AVTE is $10.31 M
What is the all time high quarterly current liabilities for Aerovate Therapeutics?
Aerovate Therapeutics all-time high quarterly total current liabilities is $17.64 M
What is Aerovate Therapeutics quarterly current liabilities year-on-year change?
Over the past year, AVTE quarterly total current liabilities has changed by -$7.32 M (-41.51%)